Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multi-centric, Comparative, Long-term Clinical Follow-Up Study for the Evidence of Safety and Performance Indicators of the Plasmafit® Revision Structan® Hip Endoprosthesis Cup

NCT04255966 is registered in ClinicalTrials.gov with Aesculap AG as lead sponsor.

NCT NCT04255966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04255966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multi-centric, Comparative, Long-term Clinical Follow-Up Study for the Evidence of Safety and Performance Indicators of the Plasmafit® Revision Structan® Hip Endoprosthesis Cup
Lead sponsor
Aesculap AG
Phase
Observational
Overall status
Active, not recruiting
Start date
April 12, 2021
Completion date
June 30, 2027
Enrollment
60 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

arthroplasty complications, degenerative osteoarthritis, femoral head avascular necrosis, fractures, hip, instability of prosthetic joint, osteolysis, prosthesis failure, rheumatic arthritis